Blair William & CO Halozyme Therapeutics, Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Blair William & CO holds 4,149 shares of HALO stock, worth $203,301. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,149

Previous 312 1229.81%

Holding current value

$203,301

Previous $16,000 1381.25%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$51.3 - $64.42 $196,838 - $247,179	3,837 Added 1229.81%	4,149 $237,000
Q2 2024 Aug 12, 2024	BUY	$37.81 - $52.4 $11,796 - $16,348	312 New	312 $16,000
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $78,517 - $116,502	-1,960 Reduced 11.55%	15,017 $854,000
Q3 2022 Nov 09, 2022	SELL	$38.53 - $51.78 $3,698 - $4,970	-96 Reduced 0.56%	16,977 $671,000
Q2 2022 Aug 10, 2022	SELL	$37.35 - $48.3 $112,983 - $146,107	-3,025 Reduced 15.05%	17,073 $751,000
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $4,891 - $6,282	-153 Reduced 0.76%	20,098 $802,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1,081 - $1,385	34 Added 0.17%	20,251 $814,000
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $29,429 - $35,511	765 Added 3.93%	20,217 $822,000
Q2 2021 Aug 12, 2021	SELL	$38.84 - $51.31 $68,008 - $89,843	-1,751 Reduced 8.26%	19,452 $883,000
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $119,517 - $155,636	-3,025 Reduced 12.49%	21,203 $884,000
Q4 2020 Feb 09, 2021	SELL	$25.81 - $43.62 $65,092 - $110,009	-2,522 Reduced 9.43%	24,228 $1.04 Million
Q3 2020 Nov 06, 2020	SELL	$25.74 - $29.63 $28,725 - $33,067	-1,116 Reduced 4.0%	26,750 $703,000
Q2 2020 Aug 12, 2020	BUY	$16.25 - $26.81 $23,611 - $38,954	1,453 Added 5.5%	27,866 $747,000
Q1 2020 May 11, 2020	BUY	$13.9 - $21.83 $69,083 - $108,495	4,970 Added 23.18%	26,413 $475,000
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $320,143 - $418,781	21,443 New	21,443 $380,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.83B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account